Literature DB >> 15557183

TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.

Carolina B López1, Bruno Moltedo, Lena Alexopoulou, Laura Bonifaz, Richard A Flavell, Thomas M Moran.   

Abstract

TLR signaling leads to dendritic cell (DC) maturation and immunity to diverse pathogens. The stimulation of TLRs by conserved viral structures is the only described mechanism leading to DC maturation after a virus infection. In this report, we demonstrate that mouse myeloid DCs mature normally after in vivo and in vitro infection with Sendai virus (SeV) in the absence of TLR3, 7, 8, or 9 signaling. DC maturation by SeV requires virus replication not necessary for TLR-mediated triggering. Moreover, DCs deficient in TLR signaling efficiently prime for Th1 immunity after infection with influenza or SeV, generating IFN-gamma-producing T cells, CTLs and antiviral Abs. We have previously demonstrated that SeV induces DC maturation independently of the presence of type I IFN, which has been reported to mature DCs in a TLR-independent manner. The data presented here provide evidence for the existence of a novel intracellular pathway independent of TLR-mediated signaling responsible for live virus triggering of DC maturation and demonstrate its critical role in the onset of antiviral immunity. The revelation of this pathway should stimulate invigorating research into the mechanism for virus-induced DC maturation and immunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557183     DOI: 10.4049/jimmunol.173.11.6882

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

Review 1.  Control of antiviral immunity by pattern recognition and the microbiome.

Authors:  Iris K Pang; Akiko Iwasaki
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.

Authors:  Tomonori Kato; Yasuji Ueda; Hiroaki Kinoh; Yasuo Yoneyama; Akinao Matsunaga; Atsushi Komaru; Yui Harada; Hiroyoshi Suzuki; Akira Komiya; Satoko Shibata; Mamoru Hasegawa; Hideki Hayashi; Tomohiko Ichikawa; Yoshikazu Yonemitsu
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

3.  Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner.

Authors:  Jesper Melchjorsen; Søren B Jensen; Lene Malmgaard; Simon B Rasmussen; Friedemann Weber; Andrew G Bowie; Sampsa Matikainen; Søren R Paludan
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling.

Authors:  Asa S Hidmark; Eva K L Nordström; Pia Dosenovic; Mattias N E Forsell; Peter Liljeström; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus.

Authors:  Masaki Mibayashi; Luis Martínez-Sobrido; Yueh-Ming Loo; Washington B Cárdenas; Michael Gale; Adolfo García-Sastre
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 6.  Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.

Authors:  Zachary C Hartman; Daniel M Appledorn; Andrea Amalfitano
Journal:  Virus Res       Date:  2007-11-26       Impact factor: 3.303

Review 7.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 8.  Toll-like receptor-independent triggering of dendritic cell maturation by viruses.

Authors:  Carolina B López; Jacob S Yount; Thomas M Moran
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Cytokine-independent upregulation of MDA5 in viral infection.

Authors:  Jacob S Yount; Thomas M Moran; Carolina B López
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis.

Authors:  Eri Yasuoka; Kazuo Oshima; Katsuto Tamai; Takeshi Kubo; Yasufumi Kaneda
Journal:  J Mol Med (Berl)       Date:  2006-10-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.